Oct 2026
METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression.
Results showed that PARP2 was highly expressed in hepatocellular carcinoma and related to its poor prognosis, and METTL3-mediated PARP2 m6A modification plays a vital tumor-promoter role in hepatocellular carcinoma progression.
Meng-Ke Li, Yan Zhao, Yuan Li
· Toxicology and Applied Pharm... · 0 citations